Assistant Professor
Pelotonia Research Center 4189
amy.gleichman@osumc.edu
Dr. Gleichman received her bachelor’s degree in Neuroscience from Carleton College before continuing on to graduate studies at the University of Pennsylvania. There, she worked with Dr. David Lynch studying the biological basis of two autoimmune diseases, anti-NMDA receptor encephalitis and anti-AMPA receptor encephalitis. She joined the lab of S. Thomas Carmichael at UCLA as a postdoctoral fellow/project scientist, where she explored the heterogeneity of astrocytes in models of different types of ischemic stroke. To facilitate this work, she concurrently developed improved astrocyte-specific viral vectors, which are now in wide use in the astrocyte field. Dr. Gleichman joined the Department of Neurological Surgery and the Department of Biological Chemistry and Pharmacology at The Ohio State University College of Medicine as an Assistant Professor in 2025.
Dr. Gleichman studies astrocytes as gene therapy targets for brain repair after stroke and in vascular dementia, two forms of ischemic brain injury. For further details, please visit her lab’s website at gleichmanlab.com.
Research Interests
- Astrocytes
- Stroke
- Vascular dementia
- Gene therapy
- Adeno-associated virus
- Lentivirus
Education
Postdoctoral fellowship: University of California – Los Angeles, Los Angeles, CA. Advisor: Dr. S. Thomas Carmichael
Ph.D, Neuroscience: University of Pennsylvania, Philadelphia, PA. Advisor: Dr. David Lynch
BA, Neuroscience: Carleton College, Northfield, MN